时间标签：数据日期 2026-11-05 · 生成时间 2026-11-05 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/11/02 – 2026/11/06 ｜ 情报发生日期 2026-11-05
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
摘要（PubMed 原文节选）
In this work, six multifunctional cyclometalated iridium(III) complexes Ir-CA-1-3 and Ir-GFB-1-3 were designed and synthesized by introducing peroxisome proliferator-activated receptor alpha (PPARα) agonists clofibrate (CA) and gemfibrozil (GFB) as derivative fragments. Their in vitro antitumor activity was systematically evaluated, and t…
对本项目的价值
参考价值：属「线粒体质量控制与氧化应激」方向；线粒体功能与氧化应激栏目可用作本项目文献库与综述素材。 ｜ 价值分 1.8/5（★★☆☆☆）
全文不可及原因
无 PMCID 且 Europe PMC / OpenAlex / Unpaywall 未提供可下载 OA 全文
原文题录
- 中文题名：氯贝丁酯与吉非罗齐偶联的环金属化铱(III) 配合物：设计、合成与抗肿瘤活性
- 英文标题：Cyclometalated iridium(III) complexes conjugated with clofibrate and gemfibrozil: design, synthesis, and antitumor activity.
- 期刊与标识：Dalton transactions (Cambridge, England : 2003) · PMID 42980385 · DOI 10.1039/d6dt02221a